» Articles » PMID: 26893526

Tree-based Methods for Individualized Treatment Regimes

Overview
Journal Biometrika
Specialty Public Health
Date 2016 Feb 20
PMID 26893526
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Individualized treatment rules recommend treatments on the basis of individual patient characteristics. A high-quality treatment rule can produce better patient outcomes, lower costs and less treatment burden. If a treatment rule learned from data is to be used to inform clinical practice or provide scientific insight, it is crucial that it be interpretable; clinicians may be unwilling to implement models they do not understand, and black-box models may not be useful for guiding future research. The canonical example of an interpretable prediction model is a decision tree. We propose a method for estimating an optimal individualized treatment rule within the class of rules that are representable as decision trees. The class of rules we consider is interpretable but expressive. A novel feature of this problem is that the learning task is unsupervised, as the optimal treatment for each patient is unknown and must be estimated. The proposed method applies to both categorical and continuous treatments and produces favourable marginal mean outcomes in simulation experiments. We illustrate it using data from a study of major depressive disorder.

Citing Articles

A Bayesian multivariate hierarchical model for developing a treatment benefit index using mixed types of outcomes.

Wu D, Goldfeld K, Petkova E, Park H BMC Med Res Methodol. 2024; 24(1):218.

PMID: 39333874 PMC: 11437666. DOI: 10.1186/s12874-024-02333-z.


Estimating optimal decision trees for treatment assignment: The case of K > 2 treatment alternatives.

Sies A, Doove L, Meers K, Dusseldorp E, Van Mechelen I Behav Res Methods. 2024; 56(8):8259-8268.

PMID: 39164562 DOI: 10.3758/s13428-024-02470-9.


Using Pilot Data for Power Analysis of Observational Studies for the Estimation of Dynamic Treatment Regimes.

Rose E, Moodie E, Shortreed S Obs Stud. 2024; 9(4):25-48.

PMID: 39005256 PMC: 11245299. DOI: 10.1353/obs.2023.a906627.


Penalized robust learning for optimal treatment regimes with heterogeneous individualized treatment effects.

Li C, Li W, Zhu W J Appl Stat. 2024; 51(6):1151-1170.

PMID: 38628447 PMC: 11018073. DOI: 10.1080/02664763.2023.2180167.


Developing an individualized treatment rule for Veterans with major depressive disorder using electronic health records.

Zainal N, Bossarte R, Gildea S, Hwang I, Kennedy C, Liu H Mol Psychiatry. 2024; 29(8):2335-2345.

PMID: 38486050 PMC: 11399319. DOI: 10.1038/s41380-024-02500-0.


References
1.
Zhang B, Tsiatis A, Davidian M, Zhang M, Laber E . Estimating Optimal Treatment Regimes from a Classification Perspective. Stat. 2013; 1(1):103-114. PMC: 3640350. DOI: 10.1002/sta.411. View

2.
Cummings J, Emre M, Aarsland D, Tekin S, Dronamraju N, Lane R . Effects of rivastigmine in Alzheimer's disease patients with and without hallucinations. J Alzheimers Dis. 2010; 20(1):301-11. DOI: 10.3233/JAD-2010-1362. View

3.
Hamburg M, Collins F . The path to personalized medicine. N Engl J Med. 2010; 363(4):301-4. DOI: 10.1056/NEJMp1006304. View

4.
Zhao Y, Kosorok M, Zeng D . Reinforcement learning design for cancer clinical trials. Stat Med. 2009; 28(26):3294-315. PMC: 2767418. DOI: 10.1002/sim.3720. View

5.
Ludwig J, Weinstein J . Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer. 2005; 5(11):845-56. DOI: 10.1038/nrc1739. View